主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ICCC
#3451
Immucell Corp
6.4
0
+0.79%
版块:
基础:
利润货币:
日范围
年范围
日变化
+0.79%
每月变动
+0.63%
6个月变化
+4.40%
年变化
+21.67%
前一天收盘价
6.3
5
Open
6.4
0
Bid
Ask
Low
6.4
0
High
6.4
0
交易量
3
市场
股票
医疗保健
ICCC
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
新闻
ImmuCell董事将在2026年年度股东大会上卸任,董事会预计将发生变动
ImmuCell directors to step down at 2026 annual meeting, board changes expected
ImmuCell宣布新高管雇佣协议及期权授予
ImmuCell announces new executive employment agreements and option grants
Niche Focus & Regulation Shape the Future of Healthcare Firms
ImmuCell Corporation (ICCC) Q4 2025 Sales/Trading Call Transcript
盈利电话会议记录:ImmuCell 2025年第四季度股价走势向好
Earnings call transcript: ImmuCell Q4 2025 sees positive stock movement
ImmuCell公司报告第四季度销售额为760万美元,将重心转向First Defense
ImmuCell reports Q4 sales of $7.6 million, shifts focus to First Defense
ImmuCell Puts Re-Tain On Pause After FDA Letter - ImmuCell (NASDAQ:ICCC)
The Zacks Analyst Blog AbbVie, The Coca-Cola, Chevron, ImmuCell and Precipio